Table 5

Clinical Outcomes at 30 Days and 1 Year

OverallMenWomenp Value
30 days
 MACCE5/140 (3.6)4/70 (5.7)1/70 (1.4)0.37
 Death2/140 (1.4)1/70 (1.4)1/70 (1.4)1.00
 Cardiac2/140 (0.7)1/70 (0.0)1/70 (1.4)1.00
 Noncardiac0/140 (0.7)0/70 (1.4)0/70 (0.0)1.00
 Reinfarction2/140 (1.4)2/70 (2.9)0/70 (0.0)0.50
 Stroke1/140 (0.7)1/70 (1.4)0/70 (0.0)1.00
 Stent thrombosis3/140 (2.1)2/70 (2.9)1/70 (1.4)1.00
 Definite2/140 (1.4)2/70 (2.9)0/70 (0.0)0.50
 Probable1/140 (0.7)0/70 (0.0)1/70 (1.4)1.00
 Ischemia-driven target lesion revascularization2/140 (1.4)2/70 (2.9)0/70 (0.0)0.50
 Target vessel revascularization2/140 (1.4)2/70 (2.9)0/70 (0.0)0.50
1 year
 MACCE9/140 (6.4)5/70 (7.1)4/70 (5.7)0.69
 Death6/140 (4.3)3/70 (4.3)3/70 (4.3)1.00
 Cardiac3/140 (1.4)1/70 (1.4)2/70 (2.9)0.57
 Noncardiac3/140 (2.9)2/70 (2.9)1/70 (1.4)0.56
 Reinfarction2/140 (1.4)2/70 (2.9)0/70 (0.0)0.16
 Stroke1/140 (0.7)1/70 (1.4)0/70 (0.0)0.31
 Stent thrombosis3/140 (2.1)2/70 (2.9)1/70 (1.4)0.55
 Definite2/140 (1.4)2/70 (2.9)0/70 (0.0)0.16
 Probable1/140 (0.7)0/70 (0.0)1/70 (1.4)0.32
 Ischemia-driven target lesion revascularization5/140 (3.6)3/70 (4.3)2/70 (2.9)0.69
 Target vessel revascularization9/140 (6.4)5/70 (7.1)4/70 (5.7)0.72

Values are n/N (%).

MACCE = major adverse cerebral and cardiovascular events (a composite of cardiac death, reinfarction, stroke, and target lesion revascularization for ischemia, in hierarchical order).

  • Ischemia-driven target lesion revascularization refers to a procedure to treat recurrent ischemia occurring within or just outside the stent.

  • The p values are based on the log-rank test.